These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2973578)

  • 1. [Plasmid resistance to 3d generation cephalosporins].
    Philippon A; Paul G; Vedel G; Nevot P
    Presse Med; 1988 Oct; 17(37):1883-9. PubMed ID: 2973578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Sirot J; Sirot D; Petit A
    Rev Infect Dis; 1988; 10(4):885-91. PubMed ID: 3055180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Pitton JS; Sirot D; Sirot J
    J Antimicrob Chemother; 1988 Mar; 21(3):301-7. PubMed ID: 3283096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of extended spectrum beta-lactamases.
    Philippon A; Ben Redjeb S; Fournier G; Ben Hassen A
    Infection; 1989; 17(5):347-54. PubMed ID: 2689354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum plasmid-mediated beta-lactamases.
    Sirot D
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():19-34. PubMed ID: 8543494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.
    Labia R; Thabaut A; Morand A; Tiwari K; Sirot D; Sirot J
    Drugs Exp Clin Res; 1989; 15(11-12):535-40. PubMed ID: 2700319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae.
    Podbielski A; Schönling J; Melzer B; Warnatz K; Leusch HG
    J Gen Microbiol; 1991 Mar; 137(3):569-78. PubMed ID: 2033379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins.
    Bauernfeind A
    Infection; 1990; 18(1):48-52. PubMed ID: 2179138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
    Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins.
    Bauernfeind A; Chong Y; Schweighart S
    Infection; 1989; 17(5):316-21. PubMed ID: 2689349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
    Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
    J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of ceftazidime in regard to different classes of beta-lactamases. The situation in 1988].
    Labia R; Barthélémy M; Peduzzi J; Morand A; Tiwari K
    Presse Med; 1988 Oct; 17(37):1890-4. PubMed ID: 2973579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava University Hospital, Zagreb, Croatia.
    Bedenić B; Schmidt H; Herold S; Monaco M; Plecko V; Kalenić S; Katíc S; Skrlin-Subić J
    J Chemother; 2005 Aug; 17(4):367-75. PubMed ID: 16167514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-spectrum beta-lactamases in clinical isolates of enterobacteria in Mexico.
    Silva J; Aguilar C; Becerra Z; López-Antuñano F; García R
    Microb Drug Resist; 1999; 5(3):189-93. PubMed ID: 10566868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
    Oksüz L; Gürler N
    Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Klebsiella oxytoca beta-lactamases: study of their action on 3d-generation cephalosporins].
    Labia R; Morand A; Guionie M; Heitz M; Pitton JS
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):611-5. PubMed ID: 3534754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.